MedPath

BAYER AG

BAYER AG logo
🇩🇪Germany
Ownership
Public
Established
1863-08-01
Employees
99.7K
Market Cap
$30.1B
Website
http://www.bayer.com
Clinical Trials
Related News

BAY38-9456 - Pivotal Trial for Diabetes Patient

Phase 3
Completed
Conditions
Diabetes Mellitus
Erectile Dysfunction
Interventions
Drug: Placebo
Drug: Levitra (Vardenafil, BAY38-9456)
First Posted Date
2008-05-15
Last Posted Date
2014-12-19
Lead Sponsor
Bayer
Target Recruit Count
790
Registration Number
NCT00678704

A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.

Phase 2
Terminated
Conditions
Carcinoma, Renal Cell
Interventions
Drug: Sorafenib (Nexavar, BAY43-9006)
Drug: Sorafenib (Nexavar, BAY43-9006) + Interferon
First Posted Date
2008-05-15
Last Posted Date
2014-12-11
Lead Sponsor
Bayer
Target Recruit Count
16
Registration Number
NCT00678288

Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections

Phase 4
Completed
Conditions
Urinary Tract Infection
Interventions
Drug: Cipro XR (Ciprofloxacin, BAYQ3939)
First Posted Date
2008-05-13
Last Posted Date
2013-10-14
Lead Sponsor
Bayer
Target Recruit Count
276
Registration Number
NCT00676533

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

Phase 3
Completed
Conditions
Gastric Acid
Human Experimentation
Interventions
Drug: Omeprazole/sodium bicarbonate
Drug: omeprazole magnesium
Drug: sodium bicarbonate
First Posted Date
2008-05-07
Last Posted Date
2015-03-11
Lead Sponsor
Bayer
Target Recruit Count
60
Registration Number
NCT00674115

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Phase 2
Completed
Conditions
Contraceptives, Oral
Interventions
Drug: Yasminelle (SH T 00186 D)
Drug: YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)
First Posted Date
2008-05-07
Last Posted Date
2014-10-13
Lead Sponsor
Bayer
Target Recruit Count
105
Registration Number
NCT00673686

Effects of Adalat LA and Coracten on Drug Levels, Blood Pressure, and Heart Rate in Fed Patients With Hypertension

Phase 4
Completed
Conditions
Hypertension
Interventions
Drug: Adalat (Nifedipine, BAYA1040)
Drug: Coracten
First Posted Date
2008-05-06
Last Posted Date
2014-12-19
Lead Sponsor
Bayer
Target Recruit Count
43
Registration Number
NCT00672113

Trial to Evaluate the Efficacy and Safety of Cipro® XR in Treating Female Patients With Lower Urinary Tract Infections

Phase 4
Completed
Conditions
Urinary Tract Infection
Interventions
Drug: Ciprofloxacin
First Posted Date
2008-05-01
Last Posted Date
2014-12-19
Lead Sponsor
Bayer
Target Recruit Count
180
Registration Number
NCT00669994

BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis

Phase 3
Completed
Conditions
Bacterial Infections
Interventions
Drug: Ciprofloxacin single dose
Drug: Ciprofloxacin triple dose
First Posted Date
2008-05-01
Last Posted Date
2014-12-19
Lead Sponsor
Bayer
Target Recruit Count
497
Registration Number
NCT00670215

Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia

Phase 4
Completed
Conditions
Erectile Dysfunction
Interventions
Drug: Placebo
Drug: Vardenafil (Levitra, BAY38-9456)
First Posted Date
2008-04-29
Last Posted Date
2014-12-17
Lead Sponsor
Bayer
Target Recruit Count
348
Registration Number
NCT00668135

Trial to Evaluate Time to Symptom Relief and Elimination of Infecting Bacteria in Treating Sinusitis With Avelox

Phase 4
Completed
Conditions
Maxillary Sinusitis
Interventions
Drug: Avelox (Moxifloxacin, BAY12-8039)
First Posted Date
2008-04-29
Last Posted Date
2014-12-19
Lead Sponsor
Bayer
Target Recruit Count
192
Registration Number
NCT00668304
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy